A Study of Baricitinib in Participants With Rheumatoid Arthritis

Clinical trial NCT04086745 · COMPLETED

Trial details

NCT number: NCT04086745
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2020-02-14
Primary completion: 2025-05-19
Enrollment: 1050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.